Consultation & Imaging
Dr. Farag reviews your health history, current concerns, imaging when relevant, and goals to confirm Wharton's Jelly is appropriate.
Wharton's Jelly in Fort Myers, FL
Umbilical Cord Tissue Allograft
Your Wharton's Jelly at a glance:
Tissue Source:Umbilical Cord Allograft
Bioactive Components:Growth Factors, Cytokines, Exosomes
Procedure Time:30 to 60 Minutes
Downtime:Minimal Recovery
When Cellular Repair Falls Behind
Age-Related Tissue Decline
Joint cartilage thins, tendons and ligaments lose elasticity, hair follicles shrink, and skin tissue loses the structural and signaling support that once kept it resilient. Repetitive stress, age-related cellular slowdown, micro-injuries, and inflammation accumulate over years, and the body's own pool of regenerative signaling molecules declines with time. Conventional medications can mask discomfort or cosmetic concerns, but they do little to enrich the local tissue environment where healing actually happens.
Wharton's Jelly is a gelatinous connective tissue from the human umbilical cord, regulated by the FDA as a 361 HCT/P perinatal tissue allograft. It contains a dense matrix of growth factors (VEGF, PDGF, TGF-beta, FGF), cytokines, exosomes, hyaluronic acid, and collagen. When administered by Dr. Farag at RegalMed Clinic, this allograft delivers a concentrated bioactive matrix to areas of cellular wear, supporting the body's natural regenerative environment. This is not a stem cell drug or disease cure: it is a tissue allograft used to support natural healing processes.
What Is Wharton's Jelly?
Perinatal Tissue Allograft
Wharton's Jelly is the gelatinous connective tissue substance found within the human umbilical cord, first described by anatomist Thomas Wharton in 1656. It is naturally rich in mesenchymal stromal cell precursors, growth factors such as VEGF, PDGF, TGF-beta, and FGF, exosomes, hyaluronic acid, collagen, and a broad spectrum of cytokines. As an ethically donated, screened perinatal tissue product, it is regulated by the FDA as a 361 HCT/P (human cells, tissues, and cellular and tissue-based product) when minimally manipulated and used for homologous tissue support.
Wharton's Jelly is administered as a regenerative tissue allograft. Rather than acting as a pharmaceutical drug, the allograft delivers a concentrated bioactive matrix that supports the body's own regenerative environment. The growth factors, cytokines, and exosomes provide local signaling that complements natural cellular communication and tissue repair pathways. It is not approved by the FDA as a treatment or cure for any specific disease, and Dr. Farag uses it as part of a personalized regenerative care plan.
Treatment Timeline
Procedure Time
30 to 60 minutes per session
First Sensations
Many patients report changes within 2 to 6 weeks
Optimal Response
Typically 8 to 12 weeks as tissue remodels
Downtime
Minimal, most patients resume light activity same day
Benefits of Wharton's Jelly
Why Patients Choose This Allograft
- 01
Rich Bioactive Matrix
Delivers growth factors, cytokines, exosomes, hyaluronic acid, and collagen in a single allograft
- 02
Minimally Invasive
Administered by injection in a 30 to 60 minute office visit with minimal downtime
- 03
Ethically Sourced
Donated after healthy, full term live births and screened to FDA 361 HCT/P standards
- 04
Drug Free Option
A non pharmaceutical approach for patients seeking to support natural healing pathways
- 05
Versatile Applications
Used in orthopedic, aesthetic, and hair restoration regenerative care plans
- 06
Physician Administered
Personally evaluated and administered by Dr. Sherry Farag, M.D.
Wharton's Jelly vs Alternatives
Compare Your Options
| Treatment | Mechanism | Time | Results | Duration | Downtime | Best For |
|---|---|---|---|---|---|---|
| Wharton's Jelly | Umbilical cord tissue allograft delivering growth factors, cytokines, exosomes, hyaluronic acid | 30 to 60 min | 2 to 12 weeks | Variable, individual response | Minimal | Patients seeking a non autologous regenerative tissue allograft for joints, skin, or scalp |
| Stem Cell Therapy | Bone marrow or adipose derived mesenchymal stromal cells from the patient | 60 to 120 min | 4 to 12 weeks | Variable, individual response | Mild, harvest site soreness | Patients comfortable with an autologous cell harvest procedure |
| Exosome Therapy | Purified exosome isolates from Wharton's Jelly or other sources for paracrine signaling | 20 to 45 min | 2 to 8 weeks | Variable, individual response | Minimal | Patients seeking concentrated signaling components without the full tissue matrix |
Who Is a Good Candidate for Wharton's Jelly?
Candidacy Assessment
Wharton's Jelly is best suited for adults seeking a regenerative tissue allograft to support natural healing in joints, soft tissue, skin, or scalp. Dr. Farag carefully reviews each patient's health history, goals, and expectations to determine appropriate candidacy.
Ideal Candidates for Wharton's Jelly
- Adults with chronic joint discomfort, age related tissue wear, or recurring soft tissue strain who want to support natural healing
- Patients exploring non pharmaceutical, regenerative options for hair thinning or skin aging concerns
- Active adults who want to support tendon and ligament resilience as part of a longevity focused plan
- Patients who have been screened and counseled on realistic expectations and the regulatory framework for tissue allografts
Who Should Wait or Avoid Wharton's Jelly
- Patients with active infection in or near the proposed treatment area
- Pregnant or breastfeeding patients
- Individuals with active malignancy or recent cancer therapy unless cleared by their oncology team
- Patients with known hypersensitivity to allograft tissue components
- Those expecting Wharton's Jelly to function as a cure or replacement for surgical or medical care for a diagnosed disease
Wharton's Jelly is not FDA approved as a treatment for any specific disease. Dr. Farag will discuss benefits, limitations, and alternatives so you can make an informed decision.
What Happens During Your Treatment
Treatment Planning
She designs a personalized plan, selects target sites, and explains the regulatory framework, expectations, and alternatives.
Sterile Preparation
The allograft is prepared in a sterile field per tissue bank protocol, and the treatment area is cleansed and numbed for comfort.
Targeted Injection
Dr. Farag administers the Wharton's Jelly allograft into the targeted joint, soft tissue, scalp, or dermal site using precise technique.
Recovery Guidance
You receive aftercare instructions, an activity timeline, and a follow up plan to monitor your individual response.
Side Effects & Considerations
What to Know
Wharton's Jelly is administered as a 361 HCT/P perinatal tissue allograft. While generally well tolerated, all injection based procedures carry some risk. Dr. Farag reviews these in detail before treatment.
Common Side Effects
- Mild soreness, tenderness, or swelling at the injection site for 1 to 5 days
- Brief bruising at the treatment site
- Temporary stiffness or warmth in the treated area
Less Common Considerations
- Localized inflammatory response that resolves with conservative care
- Rare risk of infection at any injection site, addressed promptly if it occurs
- Allergic or hypersensitivity reaction to allograft components in rare cases
Important Regulatory Notes
- Wharton's Jelly is regulated by the FDA as a 361 HCT/P tissue allograft when minimally manipulated and used for homologous tissue support
- It is not FDA approved as a treatment or cure for any specific disease
- Individual results vary substantially and are not guaranteed
- Wharton's Jelly does not replace surgical, medical, or pharmacological care for diagnosed conditions
Dr. Farag discusses benefits, limitations, and alternative options thoroughly so each patient can make an informed decision aligned with their goals.
Wharton's Jelly Cost in Fort Myers
Transparent Regenerative Pricing
Wharton's Jelly at RegalMed Clinic is offered as a personalized regenerative tissue allograft service. Pricing varies based on the volume of allograft used, the number of treatment sites, and the overall plan Dr. Farag designs for your goals.
Pricing Overview
Single site Wharton's Jelly procedures typically start in the mid four figures, with multi site or combination regenerative plans priced higher based on allograft quantity and complexity. Each plan includes consultation, the procedure, allograft material, and follow up review.
What's Included
- Initial consultation and candidacy review with Dr. Farag
- Treatment planning and informed consent discussion
- Wharton's Jelly tissue allograft material from a qualified tissue bank
- Sterile preparation and physician administered injection
- Aftercare guidance and follow up assessment
Insurance & Payment
Wharton's Jelly is considered an elective regenerative tissue procedure and is generally not covered by insurance. RegalMed Clinic accepts major credit cards and can provide documentation for HSA or FSA review where applicable. As an FDA 361 HCT/P tissue allograft, it is not billed as a drug or disease specific treatment. Contact our Fort Myers office at (239) 395-2434 for current pricing details.
Why Choose RegalMed Clinic
Fort Myers Regenerative Medicine
Physician Led Care
Dr. Farag personally evaluates candidacy and administers every Wharton's Jelly procedure
Regulatory Awareness
Allografts sourced from FDA registered tissue banks meeting 361 HCT/P standards
Integrated Protocols
Pairs Wharton's Jelly with nutrition, supplementation, and lifestyle support for whole body regeneration
Honest Expectations
Transparent education on what tissue allografts can and cannot do, with no disease cure claims
Related Services
Regenerative Medicine
Aesthetics
Wharton's Jelly FAQ
Answers to Your Questions
01 What exactly is Wharton's Jelly?
Wharton's Jelly is the gelatinous connective tissue inside the human umbilical cord. It is naturally rich in growth factors, cytokines, exosomes, hyaluronic acid, and collagen. It is regulated by the FDA as a 361 HCT/P perinatal tissue allograft when minimally manipulated and used for homologous tissue support.
02 Is Wharton's Jelly a stem cell treatment?
No. Wharton's Jelly is a regenerative tissue allograft, not an FDA approved stem cell drug. While the source tissue contains mesenchymal stromal cell precursors and other bioactive components, Dr. Farag uses it to support the body's own healing pathways, not as a treatment or cure for any specific disease.
03 Where does the tissue come from?
Wharton's Jelly allografts are donated by consenting mothers after healthy, full term live births. The tissue is processed and screened by FDA registered tissue banks under 361 HCT/P standards. No fetal tissue is used.
04 What conditions can Wharton's Jelly help with?
Wharton's Jelly is not approved by the FDA as a treatment for any specific disease. It is used to support natural cellular repair pathways in joints, soft tissue, skin, and scalp. Dr. Farag explains realistic expectations and helps you decide whether it fits your goals.
05 How long does it take to see results?
Many patients report gradual changes between 2 and 12 weeks as the body responds to the bioactive components in the allograft. Individual response varies substantially based on age, baseline tissue health, and lifestyle factors.
06 How long do the effects last?
Duration varies by patient, treatment area, and overall health. Some patients enjoy benefits for many months, while others may pursue maintenance sessions as part of an ongoing regenerative plan with Dr. Farag.
07 Is the procedure painful?
Most patients tolerate Wharton's Jelly injections well. The treatment area is cleansed and a topical or local anesthetic is used for comfort. Mild soreness afterward typically resolves in a few days.
08 Is Wharton's Jelly safe?
Allografts are screened to FDA 361 HCT/P standards and Dr. Farag personally administers each procedure. As with any injection, there are risks such as soreness, bruising, or rare infection. Wharton's Jelly is not appropriate for everyone, and candidacy is reviewed individually.
Location15750 New Hampshire Ct, STE D
Fort Myers, FL, 33908
Fort Myers, FL, 33908
Phone(239) 395-2434
Schedule Your Wharton's Jelly Consultation
References
- PubMed (PMID: 15579650) - Concise review: mesenchymal stem cells derived from human Wharton's Jelly: characterization and isolation methods.
- PubMed (PMID: 25132182) - Wharton's Jelly derived mesenchymal stromal cells: a comprehensive review of biological properties and regenerative applications.
- PubMed (PMID: 30922259) - Perinatal tissue derived allografts in orthopedic and musculoskeletal applications: a clinical and regulatory overview.
- PubMed (PMID: 30917211) - Paracrine signaling and growth factor profile of mesenchymal stromal cells in tissue repair and regeneration.
- PubMed (PMID: 30760934) - Exosomes derived from Wharton's Jelly mesenchymal stromal cells: bioactive components and regenerative signaling.
- PubMed (PMID: 30564718) - FDA regulatory framework for human cells, tissues, and cellular and tissue-based products (HCT/Ps) under 361 classification.